Important: New Login Process

We've updated our access and security system. The first time you log in, enter your work email, and we'll guide you through the process.

  • If your organization uses Single Sign-On (SSO), you will be redirected to your company's login portal.
  • If you log in with a username and password, you will be prompted to set a new password before accessing your account.

Go to the Login Page to get started.

We appreciate your cooperation during this transition. If you need assistance, please call +1 650-552-4224 or email support@biocentury.com.

BioCentury
ARTICLE | Financial News

Immune Pharma raises $18M in follow-on

November 3, 2017 6:59 PM UTC

On Oct. 19, immunology and inflammation company Immune Pharmaceuticals Inc. (NASDAQ:IMNP; SSE:IMNP) raised $18 million through the sale of 18,000 units at $1,000 in a follow-on underwritten by Maxim Group...

Get Unlimited Access
Continue reading with a free trial.
Or Purchase This Article